An independent two-stage DCF analysis by a frontier AI model.
MetLife is a behemoth in the life insurance, annuities, and employee benefits space, operating with massive scale that affords it significant competitive advantages. Its dominance in the institutional market, particularly in group benefits, provides a relatively stable and predictable base of cash flow, insulated somewhat from the vagaries of retail consumer behavior.
The core thesis for MetLife centers on its ability to steadily compound value in a normalized interest rate environment. Higher rates benefit the company's massive investment portfolio, driving increased net investment income. Combined with a disciplined approach to capital allocation—evidenced by consistent share repurchases and dividend growth—MetLife is positioned as a reliable yield engine for long-term investors, even if top-line growth remains modest.
A 4.0% free cash flow growth rate is projected, reflecting the mature nature of the life insurance industry and the steady, predictable cash generation of MetLife's core businesses as an insurance, annuities, and employee benefit programs provider, offset by the inherently lumpy nature of insurance cash flows.
An 8.0% discount rate is utilized, balancing MetLife's strong market position and stable cash generation against the inherent macroeconomic sensitivities and regulatory risks associated with the financial services sector.
A 2.0% terminal growth rate is assumed, aligning with long-term historical inflation and GDP growth expectations, acknowledging the mature state of the global insurance market.
Intrinsic value per share under varying discount rate and terminal growth rate assumptions.
| WACC ↓ / Terminal → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 1.0% | $90.00 | $75.00 | $64.29 | $56.25 | $50.00 |
| 1.5% | $100.00 | $81.82 | $69.23 | $60.00 | $52.94 |
| 2.0% | $112.50 | $90.00 | $75.00 | $64.29 | $56.25 |
| 2.5% | $128.57 | $100.00 | $81.82 | $69.23 | $60.00 |
| 3.0% | $150.00 | $112.50 | $90.00 | $75.00 | $64.29 |
■ Undervalued vs current price ■ Overvalued vs current price
The life insurance industry is mature and highly regulated. While MetLife is executing well as a provider of insurance and annuities, explosive growth is unlikely. A 4% rate reflects steady, incremental gains in market share and the realization of cost efficiencies, rather than rapid expansion.
Interest rates are a critical driver. The valuation assumes a normalized rate environment. If rates were to plummet back to zero, MetLife's investment yields would compress, negatively impacting free cash flow and lowering the intrinsic value.
The computed intrinsic value is only marginally above the current market price, resulting in a single-digit margin of safety. Given the inherent complexities in forecasting insurance cash flows, this small premium does not provide a sufficient buffer to confidently label the stock as 'UNDERVALUED'.
Disclaimer: The numbers presented on this page are for educational and entertainment purposes only. They are the result of a deterministic mathematical model fed with assumptions generated by an Artificial Intelligence (Gemini 3.1). This does not constitute investment advice. Always conduct your own due diligence before investing in the stock market.